The Blurring Line Between Semi And Bio

Law360, New York (May 14, 2012, 1:27 PM EDT) -- At the last two nanotechnology-focused events I have attended, a common topic of discussion has arisen. People in the industry are noticing that the line that has typically, and clearly, divided semiconductor technology and biotechnology, is now beginning to blur. IP practitioners need to realize that this new semi/bio combination is highly technically complex and that they may need to improve their skills or work with others who have this skill set in order to be effective in this challenging field. Whether it be in the...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.